Lizhi Zhu

Shenzhen University - Guangdong Provincial Key Laboratory of Regional Immunity and Diseases

SCHOLARLY PAPERS

1

DOWNLOADS

34

TOTAL CITATIONS

0

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

A Novel Selective ERK1/2 Inhibitor, Laxiflorin B, Targets EGFR Mutation Subtypes in Non-Small-Cell Lung Cancer

Number of pages: 54 Posted: 18 Nov 2022
Chengyao Chiang, Min Zhang, Junrong Huang, Juan Zeng, Chunlan Chen, Dongmei Pan, Heng Yang, Min Yang, Qiangqiang Han, Zou Wang, Tian Xiao, Yongdong Zou, Feng Yin, Zigang Li, Lizhi Zhu and Duo Zheng
Shenzhen University - Guangdong Provincial Key Laboratory of Regional Immunity and Diseases, Shenzhen University - Guangdong Provincial Key Laboratory of Regional Immunity and Diseases, Shenzhen University - Guangdong Provincial Key Laboratory of Regional Immunity and Diseases, Guangdong Medical University - School of Biomedical Engineering, Shenzhen University - Guangdong Provincial Key Laboratory of Regional Immunity and Diseases, Shenzhen University - Guangdong Provincial Key Laboratory of Regional Immunity and Diseases, Shenzhen University - Guangdong Provincial Key Laboratory of Regional Immunity and Diseases, Shenzhen University - Guangdong Provincial Key Laboratory of Regional Immunity and Diseases, SpecAlly Life Technology Co., Ltd., Wuhan Biobank Co., Ltd., Shenzhen University - Guangdong Provincial Key Laboratory of Regional Immunity and Diseases, Shenzhen University - Guangdong Provincial Key Laboratory of Regional Immunity and Diseases, Peking University - State Key Laboratory of Chemical Oncogenomics, Peking University - State Key Laboratory of Chemical Oncogenomics, Shenzhen University - Guangdong Provincial Key Laboratory of Regional Immunity and Diseases and Shenzhen University - Guangdong Provincial Key Laboratory of Regional Immunity and Diseases
Downloads 34 (998,694)

Abstract:

Loading...

Laxiflorin B, NSCLC, ERK1/2, AREG, EREG, natural compound